Clinical Trial Update: Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of Thymoglobulin in patients undergoing hematopoietic stem cell transplantation, focusing on HSCT-associated thrombotic microangio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation-associated Thrombotic Microangiopathy

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy | Phase 4 | Status: RECRUITING